Aptinyx, Inc.
(NASDAQ : APTX)

( )
APTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
OSHOak Street Health, Inc. -1.28%44.000.0%$123.06m
DVADaVita, Inc. 0.83%82.413.2%$70.83m
NVTAInvitae Corp. 1.83%29.541.9%$66.30m
GHGuardant Health, Inc. 6.30%86.760.0%$66.26m
ONEM1Life Healthcare, Inc. -3.19%27.640.0%$56.86m
AMEDAmedisys, Inc. 0.80%228.5611.5%$46.45m
LHCGLHC Group, Inc. -1.04%196.202.9%$45.61m
SDCSmileDirectClub, Inc. 4.13%9.320.0%$36.45m
NTRANatera, Inc. 6.19%53.491.3%$35.09m
CHEChemed Corp. 1.02%508.1410.1%$34.00m
OTRKOntrak, Inc. -6.41%45.440.0%$30.38m
NEONeoGenomics, Inc. 1.86%39.965.7%$28.82m
BIOCBiocept, Inc. 2.00%1.0210.4%$28.44m
FLGTFulgent Genetics, Inc. 1.76%41.630.8%$25.22m
OPCHOption Care Health, Inc. 2.95%12.200.0%$15.66m

Company Profile

Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.